These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34039480)

  • 21. Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.
    Alexopoulos P; Richter-Schmidinger T; Horn M; Maus S; Reichel M; Sidiropoulos C; Rhein C; Lewczuk P; Doerfler A; Kornhuber J
    J Alzheimers Dis; 2011; 26(2):207-10. PubMed ID: 21606569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE E2/E2 Is Associated with Slower Rate of Cognitive Decline with Age.
    Sweigart B; Andersen SL; Gurinovich A; Cosentino S; Schupf N; Perls TT; Sebastiani P
    J Alzheimers Dis; 2021; 83(2):853-860. PubMed ID: 34366332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of modifiable and non-modifiable risk factors with cognitive functions - a prospective, population-based, 17 years follow-up study of 3,229 individuals.
    Glans I; Nägga K; Gustavsson AM; Stomrud E; Nilsson PM; Melander O; Hansson O; Palmqvist S
    Alzheimers Res Ther; 2024 Jun; 16(1):135. PubMed ID: 38926747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
    van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
    Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
    Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between ApoE gene and psychological consequences post stroke in a Bahraini cohort.
    Donnellan C; Redha N; Al Banna M; Al Sharoqi I; Al-Jishi A; Bakhiet M; Taha S; Abdulla F; Walsh P
    Asian J Psychiatr; 2019 Jan; 39():135-142. PubMed ID: 30622009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.
    Mata IF; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Espay AJ; Revilla FJ; Devoto J; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
    Neurobiol Aging; 2017 Aug; 56():211.e1-211.e7. PubMed ID: 28526295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND.
    Palmer Allred ND; Raffield LM; Hardy JC; Hsu FC; Divers J; Xu J; Smith SC; Hugenschmidt CE; Wagner BC; Whitlow CT; Sink KM; Maldjian JA; Williamson JD; Bowden DW; Freedman BI
    Diabetes Care; 2016 Dec; 39(12):2225-2231. PubMed ID: 27703028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.
    Dilliott AA; Evans EC; Farhan SMK; Ghani M; Sato C; Zhang M; McIntyre AD; Cao H; Racacho L; Robinson JF; Strong MJ; Masellis M; Bulman DE; Rogaeva E; Black SE; Finger E; Frank A; Freedman M; Hassan A; Lang A; Shoesmith CL; Swartz RH; Tang-Wai D; Tartaglia MC; Turnbull J; Zinman L; ; Hegele RA
    Can J Neurol Sci; 2019 Sep; 46(5):491-498. PubMed ID: 31217043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein ɛ4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics.
    Oviedo DC; Perez-Lao AR; Flores-Cuadra JA; Villarreal AE; Carreira MB; Grajales SA; Britton GB
    J Alzheimers Dis; 2021; 82(s1):S313-S319. PubMed ID: 33074238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.
    Kalapatapu RK; Delucchi KL
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):219-26. PubMed ID: 23808899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment.
    Yuan B; Xie C; Shu H; Liao W; Wang Z; Liu D; Zhang Z
    J Alzheimers Dis; 2016 Oct; 54(4):1409-1423. PubMed ID: 27589521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.
    Martinelli N; Olivieri O; Shen GQ; Trabetti E; Pizzolo F; Busti F; Friso S; Bassi A; Li L; Hu Y; Pignatti PF; Corrocher R; Wang QK; Girelli D
    BMC Med Genet; 2009 May; 10():41. PubMed ID: 19439088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.
    Karcher H; Savelieva M; Qi L; Hummel N; Caputo A; Risson V; Capkun G; Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2020; 17(7):635-657. PubMed ID: 33032508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
    Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.